Monthly Archives: October 2023

Worse cardiovascular and renal outcome in male SLE patients

Abstract Systemic lupus erythematosus (SLE) in males is rare and poorly understood. Thus, still little is known about sex differences in SLE. We set out to identify sex differences regarding clinical manifestations as well as renal and cardiovascular outcomes of SLE. We analyzed patient data from the Swiss SLE Cohort Study. Cumulative clinical manifestations according […]

Hoxworth Blood Center and the Cincinnati Cyclones team up to bolster the local blood supply

Hoxworth Blood Center, University of Cincinnati, is teaming up with the Cincinnati Cyclones to ensure a steady blood supply to help local Tri-state patients in need. Individuals who donate blood or platelets between November 1 – 30 at any of Hoxworth’s seven Neighborhood Donor Centers or select mobile blood drives will receive the first-ever Cincinnati […]

Is High Urinary Albumin Linked to Sub-Clinical Cardiovascular Disease in People with Type 2 Diabetes?

Highlights Imaging tests in individuals with type 2 diabetes without symptoms of cardiovascular disease indicated that elevated albumin in the urine may be linked with sub-clinical coronary artery pathology, including coronary artery microcalcifications. Results from the study will be presented at ASN Kidney Week 2023 November 1–November 5.  Newswise — Philadelphia, PA (November 3, 2023) […]

Karyopharm Announces Clinical Trial Collaboration with Bristol Myers Squibb to Evaluate Novel CELMoD™ Agent CC- 92480 Mezigdomide in Combination with Selinexor in Patients with Relapsed/Refractory Multiple Myeloma

Karyopharm Announces Clinical Trial Collaboration with Bristol Myers Squibb to Evaluate Novel CELMoD™ Agent CC- 92480 Mezigdomide in Combination with Selinexor in Patients with Relapsed/Refractory Multiple Myeloma —  Phase 1b/2 Trial Will Investigate Mezigdomide in Combination with Selinexor  in Patients with Relapsed/Refractory Multiple Myeloma Progressing after T-cell Immunotherapies – — Expected to be Initiated 1H 2024 […]

Drawing a tube of blood could assess ALS risk from environmental toxin exposure

BYLINE: Noah Fromson Newswise — Over the last decade, research at Michigan Medicine has shown how exposure to toxins in the environment, such as pesticides and carcinogenic PCBs, affect the risk of developing and dying from amyotrophic lateral sclerosis.  Now, investigators have developed an environmental risk score that assesses a person’s risk for developing ALS, as […]

Trends in sexually transmitted and blood-borne infections in China from 2005 to 2021: a joinpoint regression model

This study showed that the overall diagnosis rate of all five STBBIs were on the rise in China from 2005 to 2021, although the rate of increase appears to be slowing. The overall diagnosis rate increased rapidly from 2005–2007 but leveled off after 2007. This suggests that although the prevention and control of STBBIs in […]